Universiti Malaya Academician Emeritus Professor Datuk Dr Lam Sai Kit described the reopening of the economy by relaxing some restrictions under the implementation of the conditional MCO starting May 4 as "far too much and too soon." This is based on the number of cases which has not gone down sufficiently for the country to consider being "out of the woods."
The COVID-19 pandemic has severely affected food security, not only in Malaysia but all over the world. With the broken supply chain, shortage in labour, closure of restaurants, and countries banning export and many other issues plaguing our food systems, there is an urgent need to realign our fragile agriculture ecosystem. Pre-pandemic issues such as ageing farmers, climate change, emerging diseases, poverty among farmers and access to technology are still unresolved, forcing us to adapt to the new normal.
Scientists at Oxford University had begun clinical trials on the coronavirus vaccine on April 23. The first human trial had recruited 510 healthy volunteers aged between 18-55 to test the new vaccine, called ChAdOx1 nCoV-19. This is following the successful test on macaque monkeys in late March. According to the university, in the "best-case scenario", any early sign whether the vaccine works on humans will be known as early as mid-June.
Science Media Centre (SMC) Malaysia in collaboration with the Malaysian Health Coalition (MHC) hosted their first webinar on Saturday to discuss strategies for the ‘new normal’ once the movement control order (MCO) is lifted. The panelists discussed many issues from the impact of long-term MCO on mental health to life after MCO and MCO exit strategies, as well as preparations for the new normal and the importance of effective science communication during the COVID-19 crisis.
Autism community requires increasing attention and awareness, especially in these challenging times. Universiti Putra Malaysia (UPM) in collaboration with GENIUS Kurnia, has launched an Autism Awareness campaign by providing several awareness activities in the forms of weekly challenges to commemorate the World Autism Month.
As the coronavirus pandemic claims lives and overwhelms health care systems throughout the world, scientists are closely watching several late-stage trials of the antiviral drug remdesivir. Developed to treat Ebola, remdesivir is now being tested against COVID-19.
Samples from this tiger were taken and tested after several lions and tigers at the zoo showed symptoms of respiratory illness. Public health officials believe these large cats became sick after being exposed to a zoo employee who was actively shedding virus.
Wearing face masks significantly reduced the amounts of airborne virus particles expelled from infected patients. Findings suggest surgical-style face masks could slow the transmission of coronavirus and influenza viruses.
Researchers may have found a specific area of the coronavirus that can be targeted with therapies and drugs. This finding is also likely to help in the development of COVID-19 vaccine.
Scientists found Ivermectin was able to stop the SARS-CoV-2 virus growing in cell culture within 48 hours. Experts say more testing is needed to know if it works well in people and safe to use.